CD8A and neoplasm: In addition, the vaccine regulated MMP‐2 activity and degraded various collagen components of tumor ECMs, which broke the ECM barrier, alleviated the immunosuppressive environment, and enhanced CD8+ T cells tumor invasion and killing.